The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitis
Open accessAbstract
Inflammmatory bowel disease (IBD) is characterized by oxidative and nitrosative stress, leucocyte infiltration and upregulation of proinflammatory cytokines. In this study, we have investigated the protective effects of curcumin, an anti‐inflammatory and antioxidant food derivative, on 2,4,6‐ trinitrobenzene sulphonic acid‐induced colitis in mice, a model for IBD. Intestinal lesions (judged by macroscopic and histological score) were associated with neutrophil infiltration (measured as increase in myeloperoxidase activity in the mucosa), increased serine protease activity (may be involved in the degradation of colonic tissue) and high levels of malondialdehyde (an indicator of lipid peroxidation). Dose–response studies revealed that pretreatment of mice with curcumin (50 mg kg−1 daily i.g. for 10 days) significantly ameliorated the appearance of diarrhoea and the disruption of colonic architecture. Higher doses (100 and 300 mg kg−1) had comparable effects. In curcumin‐pretreated mice, there was a significant reduction in the degree of both neutrophil infiltration (measured as decrease in myeloperoxidase activity) and lipid peroxidation (measured as decrease in malondialdehyde activity) in the inflamed colon as well as decreased serine protease activity. Curcumin also reduced the levels of nitric oxide (NO) and O 2− associated with the favourable expression of Th1 and Th2 cytokines and inducible NO synthase. Consistent with these observations, nuclear factor‐κ B activation in colonic mucosa was suppressed in the curcumin‐treated mice. These findings suggest that curcumin or diferuloylmethane, a major component of the food flavour turmeric, exerts beneficial effects in experimental colitis and may, therefore, be useful in the treatment of IBD. British Journal of Pharmacology (2003) 139, 209–218. doi:10.1038/sj.bjp.0705241
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
Ohkawa, H., Ohishi, N., & Yagi, K. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90738-3 · Cited by 29,297
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Hapten-induced model of chronic inflammation and ulceration in the rat colon
Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., & Wallace, J. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90904-9 · Cited by 1,829
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,656
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Ammon, H., & Wahl, M. (1991) · Planta Medica · doi:10.1055/s-2006-960004 · Cited by 1,347
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Nitric Oxide Scavenging by Curcuminoids
Sreejayan, & Rao, M. N. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,135
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · PubMed · Cited by 718
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3474 · Cited by 681
Singer, II, Kawka, D., Scott, S., Weidner, Jr., Mumford, R., Riehl, T., & Stenson, W. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70055-0 · Cited by 584
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
Laubach, V. E., Shesely, E. G., Smithies, O., & Sherman, P. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10688 · Cited by 580
Parronchi, P., Romagnani, P., Annunziato, F., Sampognaro, S., Becchio, A., Giannarini, L., Maggi, E., Pupilli, C., Tonelli, F., & Romagnani, S. (1997) · Europe PMC (PubMed Central) · Cited by 482
Brouet, I., & Ohshima, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1076 · Cited by 471
Plant-Derived Leading Compounds for Chemotherapy of Human Immunodeficiency Virus (HIV) Infection
Vlietinck, A., De Bruyne, T., Apers, S., & Pieters, L. (1998) · Planta Medica · doi:10.1055/s-2006-957384 · Cited by 417
Amelioration of chronic ileitis by nitric oxide synthase inhibition.
Miller, M. J., Sadowska-Krowicka, H., Chotinaruemol, S., Kakkis, J. L., & Clark, D. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10238-3 · Cited by 406
Curcumin Is an In Vivo Inhibitor of Angiogenesis
Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M.-T., Fisher, C., Flynn, E., & Byers, H. R. (1998) · Molecular Medicine · doi:10.1007/bf03401744 · Cited by 402
Hanauer, S. B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341307 · Cited by 400
Chan, M. M.-Y., Huang, H.-I., Fenton, M. R., & Fong, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00114-2 · Cited by 398
Joe, B., & Lokesh, B. R. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90198-8 · Cited by 396
Yang, F., de Villiers, W. J. S., McClain, C. J., & Varilek, G. W. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.12.2334 · Cited by 389
Rachmilewitz, D., Stamler, J. S., Bachwich, D., Karmeli, F., Ackerman, Z., & Podolsky, D. K. (1995) · Gut · doi:10.1136/gut.36.5.718 · Cited by 365
Markert, M., Andrews, P. C., & Babior, B. M. (1984) · Methods in Enzymology · doi:10.1016/s0076-6879(84)05048-5 · Cited by 353
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
McKenzie, S. J., Baker, M. S., Buffinton, G. D., & Doe, W. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118757 · Cited by 349
Anti–interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
Fuss, I. J., Marth, T., Neurath, M. F., Pearlstein, G. R., Jain, A., & Strober, W. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70392-6 · Cited by 268
Greatly increased luminal nitric oxide in ulcerative colitis
Lundberg, J. O. N., Lundberg, J. M., Alving, K., & Hellström, P. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90460-x · Cited by 266
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
Sharma, S., Stutzman, J. D., Kelloff, G. J., & Steele, V. E. (1994) · PubMed · Cited by 264
Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation
McCafferty, D., Mudgett, J., Swain, M., & Kubes, P. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041266 · Cited by 251
An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis
Wallace, J. L., & Keenan, C. M. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.258.4.g527 · Cited by 246
Darnay, B. G., Singh, S., Chaturvedi, M. M., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14867 · Cited by 232
A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice
Khan, I. A., Schwartzman, J. D., Matsuura, T., & Kasper, L. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13955 · Cited by 226
Experimental Autoimmune Encephalomyelitis Is Exacerbated in Mice Lacking the NOS2 Gene
Fenyk-Melody, J. E., Garrison, A. E., Brunnert, S. R., Weidner, J. R., Shen, F., Shelton, B. A., & Mudgett, J. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2940 · Cited by 224
Dietary modulation of avian coccidiosis
Allen, P. C., Danforth, H. D., & Augustine, P. C. (1998) · International Journal for Parasitology · doi:10.1016/s0020-7519(98)00029-0 · Cited by 220
Zingarelli, B., Day, B. J., Crapo, J. D., Salzman, A. L., & Szabó, C. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700872 · Cited by 217
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
Rachmilewitz, D., Karmeli, F., Okon, E., & Bursztyn, M. (1995) · Gut · doi:10.1136/gut.37.2.247 · Cited by 191
Mazumder, A., Wang, S., Neamati, N., Nicklaus, M. C., Sunder, S., Chen, J. T., Milne, G. W. A., Rice, W. G., Terrence R. Burke, & Pommier, Y. G. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960074e · Cited by 172
The selective beneficial effects of nitric oxide inhibition in experimental colitis
Hogaboam, C. M., Jacobson, K., Collins, S. M., & Blennerhassett, M. G. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.268.4.g673 · Cited by 168
Kimura, H., Miura, S., Shigematsu, T., Ohkubo, N., Tsuzuki, Y., Kurose, I., Higuchi, H., Akiba, Y., Hokari, R., Hirokawa, M., et al. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018849405922 · Cited by 164
Kawakami, K., Tohyama, M., Qifeng, X., & Saitô, A. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1307-1312.1997 · Cited by 116
Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.
Hogaboam, C. M., Vallance, B. A., Kumar, A., Addison, C., Graham, F. L., Gauldie, J., & Collins, S. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119823 · Cited by 115
Kakar, S. S., & Roy, D. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90413-8 · Cited by 113
Gescher, A. J., Pastorino, U., Plummer, S. M., & Manson, M. M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00640.x · Cited by 105
Gilkeson, G. S., Mudgett, J. S., Seldin, M. F., Ruiz, P., Alexander, A. A., Misukonis, M. A., Pisetsky, D. S., & Weinberg, J. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.365 · Cited by 102
Effects of Chronic Nitric Oxide Synthase Inhibition on TNB-induced Colitis in Rats
Pfeiffer, C. J., & Qiu, B. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05749.x · Cited by 85
Expression of nitric oxide synthase in ulcerative colitis
Godkin, A. J., de Belder, A., VILLA, L., WONG, A., Beesley, J. E., Kane, S. P., & Martin, J. (1996) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1996.tb02131.x · Cited by 76
Zingarelli, B., Cuzzocrea, S., Szabó, C., & Salzman, A. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37899-1 · Cited by 68
Protease Activity in a Hapten-Induced Model of Ulcerative Colitis in Rats
Hawkins, J. V., Emmel, E. L., Feuer, J. J., Nedelman, M. A., Harvey, C., Klein, H. J., Rozmiarek, H., Kennedy, A. R., Lichtenstein, G. R., & Billings, P. C. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018887832465 · Cited by 66
Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis
Cuzzocrea, S., McDonald, M. C., Mazzon, E., Dugo, L., Lepore, V., Fonti, M. T., Ciccolo, A., Terranova, M. L., Caputi, A. P., & Thiemermann, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00623-3 · Cited by 53
Manipulation of the l -arginine-nitric oxide pathway in experimental colitis
Neilly, P., Kirk, S., Gardiner, K. R., Anderson, N. H., & Rowlands, B. J. (1995) · British journal of surgery · doi:10.1002/bjs.1800820913 · Cited by 28
Intracolonic Release of Nitric Oxide During Trinitrobenzene Sulfonic Acid Rat Colitis
Ferretti, M., Gionchetti, P., Rizzello, F., Venturi, A., Stella, P., Corti, F., Mizrahi, J., Miglioli, M., & Campieri, M. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018897519880 · Cited by 20
Ambrose, N. S. (1987) · Current Opinion in Gastroenterology · doi:10.1097/00001574-198705000-00009 · Cited by 14
(2001) · PubMed
Cited by
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Curcumin, a component of golden spice: From bedside to bench and back
Prasad, S., Gupta, S. C., Tyagi, A. K., & Aggarwal, B. B. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.04.004 · Cited by 858
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
Gupta, S. C., Patchva, S., Koh, W., & Aggarwal, B. B. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05648.x · Cited by 856
Curcumin: Getting Back to the Roots
SHISHODIA, S., SETHI, G., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.010 · Cited by 715
Metadata
- Authors
- Ukil, A., Maity, S., Karmakar, S., Datta, N., Vedasiromoni, J. R., & Das, P. K.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 139
- Issue
- 2
- Pages
- 209-218
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2153558783
- Cited by
- 268
- References
- 55
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.